The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study

16 April 2023 (09:40 - 10:40)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Mr Maxim Grymonprez

University Hospital Ghent, Gent (Belgium)

7 More presentations in this session

Presentation thumbnail

5 years incident stroke, heart failure, acute myocardial infarction, and death in patients having undergone atrial fibrillation ablation according to BMI

Doctor J. Toennesen (Gentofte, DK)

Abstract Slides

Presentation thumbnail

Statin use improves the outcomes in patients with atrial fibrillation: A population-based study

Miss J. Huang (Hong Kong, HK)

Abstract Slides

Presentation thumbnail

Morphology-Voltage-P-wave-duration (MVP) score to select patients for continuous atrial fibrillation screening to prevent stroke

Doctor L. Xing (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide registry study.

Doctor M. Lehto (Helsinki, FI)

Abstract Slides

Presentation thumbnail

Racial differences in atrial fibrillation-related bleeding and mortality.

Doctor K. Dongseon (Anyang-Si- Gyeonggi-Do, KR)

Abstract Slides

Access the full session

Session thumbnail

Atrial Fibrillation - Round 1 - Stroke - OAC

The Event

Event poster

EHRA 2023

16 April 2023 09:40 CET

You may be interested in

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

Congress Session

Oral anticoagulation in subclinical atrial fibrillation

Congress Presentation

Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - con

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources